OC-0130: Prostatic sarcomas: a large multicentric Rare Cancer Network study
نویسندگان
چکیده
منابع مشابه
Non – Detection of HPV DNA in Prostatic Cancer and Benign Prostatic Hyperplasia: a case- control study in Kerman
Background: Different studies assessed the role of inflammation in malignancy of different organs. Prostatitis has been suggested as a cause of cancer and BPH. Till now, more than 100 types of human Papilloma virus (HPV) are recognized including low and high-risk groups for carcinogenesis. Among them HPV-16 and HPV-18 have shown further association with cancer. Regarding the pr...
متن کاملA rare case of prostatic brucellosis mimicking prostate cancer.
Brucellosis, with 500,000 new cases occurring annually is one of the most common zoonotic diseases in the world. In Turkey its incidence is 0.59/100000 and seropositivity rate is 1.8% in the healthy population. Incidence of the disease is high among the people who live in rural areas, consume raw milk and dairy products, livestock raisers, farmers, veterinarians, butchers and laboratory workers...
متن کاملPrimary Hepatic Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study
Primary hepatic lymphoma (PHL) is a rare malignancy. We aimed to assess the clinical profile, outcome and prognostic factors in PHL through the Rare Cancer Network (RCN). A retrospective analysis of 41 patients was performed. Median age was 62 years (range, 23-86 years) with a male-to-female ratio of 1.9:1.0. Abdominal pain or discomfort was the most common presenting symptom. Regarding B-sympt...
متن کاملMucosal Kaposi sarcoma, a Rare Cancer Network study
Kaposi's sarcoma (KS) most often affect the skin but occasionally affect the mucosa of different anatomic sites. The management of mucosal KS is seldom described in the literature. Data from 15 eligible patients with mucosal KS treated between 1994 and 2008 in five institutions within three countries of the Rare Cancer Network group were collected. The inclusion criteria were as follows: age >1...
متن کاملA very rare case of metachronous multicentric giant cell tumor of bone with benign lung metastasis in form of a very large mass lesion
Giant cell tumour (GCT) is a benign, locally aggressive tumour of the bone that accounts for 5% of primary bone tumours and 21% of benign bone tumours. This tumour more commonly presents as a single (solitary) lesion; however, it may appear with multiple (multicentric) lesions in less than 1% of the cases. According to the literature, 1-9% of solitary GCTs metastasizes to the lung, more commonl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2017
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(17)30573-x